Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Glenmark Pharms Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for GLENMARK PHARMS, and what generic and branded alternatives to GLENMARK PHARMS drugs are available?

GLENMARK PHARMS has ninety-one approved drugs.

There are nine tentative approvals on GLENMARK PHARMS drugs.

Summary for Glenmark Pharms
US Patents:0

Drugs and US Patents for Glenmark Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms ROSUVASTATIN CALCIUM rosuvastatin calcium TABLET;ORAL 079172-004 Jul 19, 2016 AB RX No No   Start Trial   Start Trial
Glenmark Pharms Ltd POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 203562-001 Jul 26, 2016 AB1 RX No No   Start Trial   Start Trial
Glenmark Pharms Ltd OLMESARTAN MEDOXOMIL olmesartan medoxomil TABLET;ORAL 203281-001 May 25, 2017 AB RX No No   Start Trial   Start Trial
Glenmark Pharms Ltd EZETIMIBE AND SIMVASTATIN ezetimibe; simvastatin TABLET;ORAL 208699-003 Jun 27, 2019 AB RX No No   Start Trial   Start Trial
Glenmark Pharms Ltd CLOBETASOL PROPIONATE clobetasol propionate AEROSOL, FOAM;TOPICAL 210809-001 Feb 15, 2019 AB1 RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.